News Living Cell Technologies to meet with the US Food and Drug Administration (FDA) Living Cell Technologies (ASX: LCT) will meet with the US Food and Drug Administration (FDA) on Friday 9th December to discuss requirements for initiation of the first human study of its NeurotrophinCell product. Related Document |